A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients

Completed · Phase 3

Conditions studied: Hypertension

In brief

A study to determine the safety, efficacy and superiority of nebivolol to placebo for the treatment of elevated blood pressure in patients with mild to moderate hypertension.

Key facts

Study ID

NCT00200473

Run by

Mylan Bertek Pharmaceuticals

People needed

800

Starts

2001-09-01

Expected to finish

2003-03-01

Last updated by the study team

2005-09-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• An average sitting diastolic blood pressure of greater then or equal to 95 mmHg and less then or equal to 109 mmHg at baseline

You may not qualify if…

• Recent myocardial infarction or stroke
• Secondary hypertension
• Contraindications to beta-blocker therapy or discontinuation of prior antihypertensive agents
• Pregnancy, nursing or women of childbearing age not using appropriate contraception

Where it is running

• Mylan Pharmaceuticals Inc. — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.